Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Ryan

Showing results (161-170 of 274) with videos related to

Pageof 28
Sort By:
Investigational New Drugs|April 10, 2013
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patientsDouglas A Rubinson, Howard S Hochster, David P Ryan, et al.
Investigational New Drugs|July 13, 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinomaMarcus Noel, Eileen M O'Reilly, Brian M Wolpin, et al.
Annals of Surgical Oncology|December 25, 2019
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic CholangiocarcinomaAlicia C Smart, Lipika Goyal, Nora Horick, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomasJohn V Heymach, Jayesh Desai, Judith Manola, et al.
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
The Oncologist|July 23, 2020
The Art of Oncology: COVID-19 EraKerry L Reynolds, Samuel J Klempner, Aparna Parikh, et al.
Contemporary Clinical Trials|October 28, 2022
Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancerKelly E Irwin, Catherine A Callaway, Amy E Corveleyn, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreasClifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
JAMA Oncology|February 10, 2022
Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer: A Randomized Clinical TrialRyan D Nipp, Nora K Horick, Carolyn L Qian, et al.
Pageof 28

Showing results (161-170 of 274) with videos related to

Sort By:
Pageof 28
Investigational New Drugs|April 10, 2013
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patientsDouglas A Rubinson, Howard S Hochster, David P Ryan, et al.
Investigational New Drugs|July 13, 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinomaMarcus Noel, Eileen M O'Reilly, Brian M Wolpin, et al.
Annals of Surgical Oncology|December 25, 2019
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic CholangiocarcinomaAlicia C Smart, Lipika Goyal, Nora Horick, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomasJohn V Heymach, Jayesh Desai, Judith Manola, et al.
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
The Oncologist|July 23, 2020
The Art of Oncology: COVID-19 EraKerry L Reynolds, Samuel J Klempner, Aparna Parikh, et al.
Contemporary Clinical Trials|October 28, 2022
Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancerKelly E Irwin, Catherine A Callaway, Amy E Corveleyn, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreasClifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
JAMA Oncology|February 10, 2022
Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer: A Randomized Clinical TrialRyan D Nipp, Nora K Horick, Carolyn L Qian, et al.
Pageof 28